Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion
Open Access
- 1 November 2002
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 43 (11) , 1875-1880
- https://doi.org/10.1194/jlr.m200166-jlr200
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Evaluation of phospholipid transfer protein and cholesteryl ester transfer protein as contributors to the generation of preβ-high-density lipoproteinsBiochemical Journal, 2001
- Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiencyNature Medicine, 2001
- The impact of phospholipid transfer protein (PLTP) on HDL metabolismAtherosclerosis, 2001
- 1999 George Lyman Duff Memorial LectureArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Human Plasma Phospholipid Transfer Protein Increases the Antiatherogenic Potential of High Density Lipoproteins in Transgenic MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.Journal of Clinical Investigation, 1996
- High density lipoproteins and coronary heart diseaseAtherosclerosis, 1996
- Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.Journal of Clinical Investigation, 1992
- Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasmaAtherosclerosis, 1991
- A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samplesAnalytical Biochemistry, 1978